SAT0021 HUMAN CD4 T CELLS AND SYNOVIAL FIBROBLASTS COOPERATE TO PROMOTE INFLAMMATION IN THE RA SYNOVIAL JOINT
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by synovial tissue proliferation and degradation of articular cartilage. Activated synovial fibroblasts proliferate and express matrix-degrading proteases, adhesion molecules and proinflammatory cytokines, which contribute to cartilage and joint destruction. Moreover, synovial cell activation correlates with infiltration of inflammatory lymphocytes and monocytes which in turn contribute to synoviocyte activation, thus further exacerbating inflammation. Objectives: The functional relationship linking fibroblasts and T lymphocytes in this complex microenvironment has yet to be characterised. Therefore, we established an in vitro model to examine the outcomes of co-culturing activated human CD4 T cells with RA synovial fibroblasts. Methods: Co-culture assays were carried out using immortalised K4IM RA synovial fibroblasts or synovial fibroblast cells derived from arthroscopy biopsies of RA patients. Human CD4 T cells were stained with a proliferation-tracking dye and co-cultured with pre-seeded synovial fibroblasts for 5 days. The resulting cell cultures and supernatants were examined for proliferation, cytokine production, secretion of matrix metalloproteinases and expression of adhesion molecules. Results: We found that CD4 T cells and K4IM cells reciprocally induced an increased expression of adhesion molecules ICAM and VCAM. Furthermore, co-culture of CD4 T cells and synovial fibroblasts resulted in proliferation of CD4 T cells expressing increased levels of the proinflammatory cytokines IFN-γ and IL17a and RANKL after 5 days. Lastly, co-culture of T cells and synovial fibroblasts resulted in secretion of IL-6, IL-8, IFN-γ and IL-17a and matrix metalloproteinases MMP-1 and MMP-3.
Conclusions:
These results indicate that CD4 T cells work mutually with synoviocytes to create an inflammatory microenvironment likely to promote joint destruction. Future studies will characterise the role of glucose metabolism in these cells and investigate if metabolism is intrinsically coupled to effector functions in these cells. Background: Epigenetic regulation of immune cell types could be critical for the development and maintenance of autoimmune diseases like Rheumatoid Arthritis (RA). B cells are highly relevant in RA, since patients express autoantibodies and depleting this cell type is a successful therapeutic approach. Epigenetic variation, such as DNA methylation, may mediate the pathogenic activity of B cells. Objectives: In this study, we performed an epigenome-wide association study (EWAS) for RA with three different replication cohorts, to identify disease-specific alterations in DNA methylation in B cells. Methods: Genomic methylation in isolated B lymphocytes was assayed on the Illumina HumanMethylation450 BeadChip, assaying >450,000 different CpG sites. Differential methylated positions (DMPs) were identified in a discovery cohort using a single-point analysis using logistic regression, as well as a pathway-level analysis using a newly developed permutation-based method. A discovery cohort of 50 RA patients and 75 healthy controls from Spain was used to identify the most differentially methylated regions after multiple test correction. Using an independent sample of 15 patients and 15 controls from the same population we performed a replication analysis of the most significant CpG sites and pathways. Using an additional case-control sample of 24 individuals from the UK we provided further evidence of association of the DMPs with RA. Finally, in silico datta from a cohort of systemic lupus erythematosus patients (SLE, n=47) and controls (n=56) from the US, we tested the association of the associated DMPs. Results: A total of 64 CpG sites were found to be differentially methylated in RA patients compared to controls in the discovery stage after multiple test correction (q<0.05). Six biological pathways were also differentially methylated in RA B cells. Analysis of these epigenetic changes in the independent Spain cohort replicated the association of 10 CpG sites located on 8 genes and 2 intergenic regions. Differential methylation at the CBL signaling pathway was also replicated. Using the UK case-control cohort, association between RA risk and methylation levels at CD1C (P=2.26x10 -9 ) and TNFSF10 (P=1.67x10 -8 ) loci was further validated. Most of the replicated DMPs associated with RA were also found to be associated with differential methylation in SLE B cells. Objectives: Interferon-free direct-acting antiviral (DAA)-based therapy has proven to be very effective in patients with hepatitis C virus-cryoglobulinemia vasculitis (HCV-CV). However, their mechanisms of action and their effects on cellular immunity remain poorly defined. Methods: 27 HCV-CV patients treated with DAA therapy, 12 healthy donors (HD) and 12 HCV were included. We investigated the effects of DAA-based therapy on cellular and cytokine abnormalities in HCV-CV patients by flow cytometry, cytokine Multiplex and enzyme-linked immunosorbent assay. -/low memory B cells were negatively correlated with regulatory T cells (Tregs) (P=0.03), and positively correlated with Tfh (P=0.03) and serum cryoglobulin levels (P=0.01). DAA-based therapy was associated with an increase in Tregs frequency (1.5% ± 0.18% versus 2.1% ± 0.18%), and decreased IgM + CD21 -/low memory B cells and Tfh percentage (35.7% ± 6.1% versus 14.9% ± 3.8%, and 12% ± 1.3% versus 8% ± 0.9%, respectively). B lymphocyte stimulator receptor 3 and programmed death-ligand 1 staining expression on B cells increased in HCV-CV after DAA-based therapy (MFI 37±2.4 versus 47±2.6, P<0.01; and 29±7.3 versus 48±9.3, P<0.05 respectively). 
Conclusions

